As we grow older and enter middle age, thoughts about our health and its implications for the future become more pronounced: particularly when it comes to cancer. The mere mention of “the…
Read More ➝
Menopause happens to all women at some point in their lives. Even though it is a normal and natural process, there is still a gap in knowledge surrounding menopause — nearly half…
Read More ➝
May is mental health awareness month, so this month we want to talk about menopause and mental health. Did you know that depression in women doubles around menopause?1,2 While most people know…
Read More ➝
The first signs of menopause are the symptoms women experience during a period called perimenopause, which can start up to 10 years before menopause. Since menopause is defined by not having a…
Read More ➝
Last month, we looked at two different types of genetic variants: BRCA variants and the KRAS-variant. Both BRCA and KRAS are pathogenic variants that are linked to an increased risk of breast…
Read More ➝
This post explores BRCA variants vs. the KRAS-variant and is part two of our series on understanding the different genetic causes of cancer. In part one of our series, we compared genetic…
Read More ➝
Learn more about how our genes play a role in cancer development in this two-part series comparing different genetic variants and genetic mutations. Genes and cancer development: Gene Variants vs Mutations Cancer…
Read More ➝
Want to learn more about menopause, menopausal hormone therapy (MHT), formerly hormone replacement therapy (HRT), estrogen, and breast cancer risk? Why not sit down, pop in some headphones, and listen to this…
Read More ➝
Over the years, Mirakind has shared research and information about the KRAS-variant and how it can have many health implications – from cancer to autoimmunity to response to hormone replacement therapy. Now,…
Read More ➝
Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of MHT in the KRAS-variant patients, and even autoimmunity! Now, we want…
Read More ➝
We want to start with the basics about Menopausal Hormone Therapy (MHT) so you can get up to speed on the importance of MiraKind’s new study. In this article, we’ll cover what…
Read More ➝
When our team came across a recent Los Angeles Times Article entitled, “Once and for all: Hormone replacement is good for women” we were very intrigued. What we learned from this game-changing…
Read More ➝
We had an excellent question from a MiraKind study participant. They wanted to know, “If I participate in a study will you send me my KRAS-variant results?” Unfortunately, the answer is no….
Read More ➝
We received a great question from a friend of a patient asking, “since she knows she has a BRCA mutation, is it necessary to find out if she also has the KRAS-variant?…
Read More ➝
We had an excellent question from a participant who has the KRAS-variant and had chosen to have her ovaries removed. She asked her OB/GYN if she still needed to have pelvic exams…
Read More ➝